Momentis Innovative Surgery Ltd., headquartered in Illinois, is a pioneering force in the medical device industry, specialising in advanced surgical solutions. Founded in 2015, the company has rapidly established itself as a leader in minimally invasive surgical technologies, focusing on enhancing patient outcomes and operational efficiency. With a commitment to innovation, Momentis offers a range of unique products, including state-of-the-art surgical instruments and integrated systems designed to streamline procedures. Their cutting-edge solutions are distinguished by their precision and adaptability, catering to various surgical specialties. Recognised for its contributions to the field, Momentis Innovative Surgery Ltd. continues to expand its operational reach across major regions in the United States, solidifying its market position through strategic partnerships and a dedication to research and development.
How does Momentis Innovative Surgery Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Momentis Innovative Surgery Ltd.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Momentis Innovative Surgery Ltd., headquartered in Israel (IL), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Momentis Innovative Surgery Ltd. appears to be in the early stages of establishing its climate commitments and emissions reporting. Without inherited data from a parent or related organization, the company has not yet set specific targets for emissions reduction or engaged in initiatives such as the Science Based Targets initiative (SBTi) or other industry-standard climate frameworks. In the context of the broader industry, it is essential for companies like Momentis to develop and implement robust climate strategies to align with global sustainability goals and enhance their environmental performance.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Momentis Innovative Surgery Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
